Shilpa Medicare commissions ADC manufacturing facility via subsidiary

Shilpa Medicare commissions ADC manufacturing facility via subsidiary. A state-of-the-art GMP facility for Antibody Drug Conjugates has been commissioned by Shilpa Biologicals, a material subsidiary. This marks a strategic expansion into high-value biopharma products. The move strengthens its footprint in the global specialty pharmaceuticals market.

📊 STOCKS: SHILPAMED | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #ADC